| Jane E Durkin, DO | |
|
16 Church St, Dallas, PA 18612-1136 | |
| (570) 675-2111 | |
| (570) 675-6545 |
| Full Name | Jane E Durkin |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 16 Church St, Dallas, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740249663 | NPI | - | NPPES |
| 2339592 | Other | PA | AETNA (HMO) |
| 2Y2106 | Other | PA | HEALTHNET |
| 4109937 | Other | PA | AETNA (PPO) |
| 597094 | Other | PA | BLUE SHIELD |
| 77147 | Other | PA | MED PLUS |
| 001196440-0006 | Medicaid | PA | |
| 002456 | Other | PA | FIRST PRIORTY |
| 40005H | Other | PA | EPSDT |
| 080165160 | Other | PA | PALMETTO GBA/MC RAILROAD |
| 54288 | Other | PA | GEISINGER HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS006625L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Homebound Health Services Inc | Shavertown, PA | Home health agency |
| Angel's Touch Home Care, Llc | West pittston, PA | Home health agency |
| Pathways Healthcare | Kingston, PA | Home health agency |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Wilkes-barre General Hospital | Wilkes-barre, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Meadows Nursing And Rehabilitation Center | Dallas, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steffie Enterprises, Inc | 0840225736 | 354 |
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Most people living in the U.S. disagree with the way liberals and Christian conservatives approach religious issues in the public forum - including topics such as abortion and human embryonic stem cell research - according to a recently released national survey on politics and religion, the Los Angeles Times reports.
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Infants and young children who undergo surgery to insert ventilation tubes in their ears as a treatment for ear infections have hearing levels comparable to normal children 14 years later, although children with more serious disease may require repeat procedures or other ear surgery, according to two studies in the April issue of Archives of Otolaryngology-Head & Neck Surgery.
› Verified 8 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Most people living in the U.S. disagree with the way liberals and Christian conservatives approach religious issues in the public forum - including topics such as abortion and human embryonic stem cell research - according to a recently released national survey on politics and religion, the Los Angeles Times reports.
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Infants and young children who undergo surgery to insert ventilation tubes in their ears as a treatment for ear infections have hearing levels comparable to normal children 14 years later, although children with more serious disease may require repeat procedures or other ear surgery, according to two studies in the April issue of Archives of Otolaryngology-Head & Neck Surgery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jane E Durkin, DO 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Jane E Durkin, DO 16 Church St, Dallas, PA 18612-1136 Ph: (570) 675-2111 |
News Archive
Most people living in the U.S. disagree with the way liberals and Christian conservatives approach religious issues in the public forum - including topics such as abortion and human embryonic stem cell research - according to a recently released national survey on politics and religion, the Los Angeles Times reports.
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
Infants and young children who undergo surgery to insert ventilation tubes in their ears as a treatment for ear infections have hearing levels comparable to normal children 14 years later, although children with more serious disease may require repeat procedures or other ear surgery, according to two studies in the April issue of Archives of Otolaryngology-Head & Neck Surgery.
› Verified 8 days ago
Dr. Elise Mester, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Church St, Dallas, PA 18612 Phone: 570-675-2111 Fax: 570-675-6545 | |
Dr. Kara A. Brezinski-clark, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Lt Michael Clear Drive, Dallas, PA 18612 Phone: 570-675-2000 Fax: 570-675-1806 | |
Dr. Michael A. Kovalick, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Lt Michael Cleary Dr, Dallas, PA 18612 Phone: 570-675-2000 Fax: 570-675-1806 | |
Ms. Lindsay Theresa Denion, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Lt Michael Cleary Dr, Dallas, PA 18612 Phone: 570-675-2000 Fax: 570-675-1806 | |
Dr. Millicent Owusu Tiwaah, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 114 Lt Michael Cleary Dr, Dallas, PA 18612 Phone: 570-675-2000 Fax: 570-675-1806 | |
Dr. Kurt Dalen Maas, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 609 Main Rd, Dallas, PA 18612 Phone: 570-675-8730 Fax: 570-675-7771 | |
Dr. Leo Mitri Hartz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 218 Hillside Two, Dallas, PA 18612 Phone: 570-674-8927 Fax: 570-674-4988 |